Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $4.7 million.

  • Coeptis Therapeutics Holdings' Shares Outstanding (Diluted Average) fell 8807.96% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year decrease of 8807.96%. This contributed to the annual value of $1.9 million for FY2024, which is 4983.58% up from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Shares Outstanding (Diluted Average) is $4.7 million, which was down 8807.96% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Shares Outstanding (Diluted Average) registered a high of $39.8 million during Q3 2024, and its lowest value of $1.3 million during Q4 2023.
  • In the last 5 years, Coeptis Therapeutics Holdings' Shares Outstanding (Diluted Average) had a median value of $12.8 million in 2022 and averaged $15.4 million.
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Shares Outstanding (Diluted Average) soared by 9805.59% in 2023 and then plummeted by 9135.43% in 2025.
  • Coeptis Therapeutics Holdings' Shares Outstanding (Diluted Average) (Quarter) stood at $10.9 million in 2021, then surged by 30.98% to $14.3 million in 2022, then plummeted by 91.01% to $1.3 million in 2023, then surged by 49.84% to $1.9 million in 2024, then surged by 146.54% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, $3.7 million for Q2 2025, and $3.1 million during Q1 2025.